Mesenchymal-to-Endothelial Transition in Kaposi Sarcoma: A Histogenetic Hypothesis Based on a Case Series and Literature Review

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gurzu, Simona ^a   Ciortea, Diana ^a   Munteanu, Teodora ^a   Kezdi Zaharia, Iringo ^a   Jung, Ioan ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD31 ANTIGEN; CD34 ANTIGEN; CYCLOOXYGENASE 2; ENDOGLIN; SMOOTH MUSCLE ANTIBODY; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOPHENOTYPING; KAPOSI SARCOMA; MALE; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SPINDLE CELL; VIRUS EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CELL TRANSDIFFERENTIATION; ENDOTHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MESODERM; MIDDLE AGED; SARCOMA, KAPOSI; YOUNG ADULT;

EID: 84881139073     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071530     Document Type: Article

References (46)

1. Kaposi M, (1872) Idiopatisches multiples Pigmentsarcom der Haut. Arch Dermatol Syph 3: 265-273.
2. Babal P, Pec J, (2003) Kaposi's sarcoma- still an enigma. J Eur Acad Dermatol Venereol 17: 377-380.
3. Kandemir NO, Gun BD, Bahadir B, Yurdakan G, Ozdemir N, et al. (2010) C-Kit (CD117) expression in classic Kaposi's sarcoma. Clin Exp Dermatol 35: 525-30.
4. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-9.
5. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, et al. (1996) Seroconversion to antibodies against Kaposi's sarcoma associated herpesvirus related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335: 233-241.
6. Miettinen M, Sarlomo-Rikala M, Lasota J, (2000) KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod Pathol 13: 536-541.
7. Ramirez-Amador V, Martinez-Marta G, Gonzalez-Ramirez I, Anaya-Saavedra G, de Almeida OP, (2009) Clinical, histological and immunohistochemical findings in oral Kaposi's sarcoma in a series of Mexican AIDS patients. Comparative study. J Oral Pathol Med 38: 328-333.
8. Li C, Gardy R, Seaon BK, Duff SE, Abdalla S, et al. (2003) Both high intratumoral microvessel density and elvated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer 88: 1424-1431.
9. Jung I, Gurzu S, Raica M, Cimpean AM, Szentirmay Z, (2009) The differences between the endothelial area marked with CD31 and CD105 in colorectal carcinomas by computer-assisted morphometrical analysis. Rom J Morphol Embryol 50: 239-243.
10. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, et al. (2001) Human reserve pluripotent mesenchymal stem cells are present in the connective tissue of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264: 51-62.
11. Gurzu S, Bara T, Jung I, (2013) Inflammatory myofibroblastic tumor in the colon. Case report and hypothesis about its histogenesis. J Clin Oncol 2013;.
12. Gurzu S, Jung I, (2012) Male breast cellular myofibroblastoma with a rich reticulinic network- case report. Am J Mens Health 6: 344-348.
13. Maio M, Altomonte M, Fonsatti E, (2006) Is it the primetime for endoglin (CD105) in the clinical setting?. Cardiovasc Res 69: 781-783.
14. Ciernik IF, Krayenbühl Ciernik BH, Cockerell CJ, Minna JD, Gazdar AF, et al. (1995) Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma. Clin Cancer Res 1: 1119-1124.
15. Miettinen M, Sobin LH, Sarlomo-Rikala M, (2000) Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 13: 1134-1142.
16. Simonart T, Degraef C, Heenen M, Hermans P, Van Vooren JP, et al. (2002) Expression of the fibroblast/macrophage marker 1B10 by spindle cells in Kaposi's sarcoma lesions and by Kaposi's sarcoma-derived tumor cells. J Cutan Pathol 29: 72-78.
17. Wu AW, Gu J, Li ZF, Ji JF, Xu GW, (2004) COX-2 expression and tumor angiogenesis in colorectal cancer. World J Gastroenterol 10: 2323-2326.
18. Takasu S, Tsukamoto T, Cao XY, Toyoda T, Hirata A, et al. (2008) Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosoureatreated K19-C2mE transgenic mice,. Cancer Sci 99: 2356-2364.
19. Balan R, Simion N, Giusca SE, Grigoras A, Gheuca-Solovastru L, et al. (2011) Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions. Rom J Morphol Embryol 52: 1187-1194.
20. Uldrick TS, Wyvill KM, Kumar P, O'Mahoni D, Bernstein W, et al. (2012) Phase II study of Bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol 30: 1476-1483.
21. Roy D, Sin SH, Lucas A, Venkataramanan R, Wang L, et al. (2013) mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis. Cancer Res 73: 2235-2246.
22. Friedenstein AJ, Gorskaja JF, Kulagina NN, (1976) Fibroblasts precursors in normal and irradiated mouse hematopoietic organs. 4: 267-274.
23. Krampera M, Franchini M, Pizzolo G, Aprili G, (2007) Mesenchymal stem cell: from biology to clinical use. Blood Transfus 5: 120-129.
24. Liu Y, Liu L, Ma X, Yin Y, Tang B, Li Z, (2013) Characteristics and neural-like differentiation of mesenchymal stem cells derived from foetal porcine bone marrow. Biosci Rep DOI: 10.142/BSR20120023.
25. Yamanka S, Takahashi K, (2006) Induction of puripotent stem cells from mouse fibroblast cultures. Tanpakushitsu Kakusan Koso 51: 2346-2351.
26. Ceafalan L, Gherghiceanu M, Popescu LM, Simionescu O, (2012) Telocytes in human skin; are they involved in skin regeneration?. J Cell Mol Med 16: 1405-1420.
27. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A, (2012) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
28. Gerlach JC, Over PJ, Turner ME, Thompson RL, Foka HG, et al. (2012) Perivascular mesenchymal progenitors in human fetal and adult liver. Stem Cells Dev 21: 3258-69.
29. Castrechini NM, Murthi P, Qin S, Kusuma GD, Wilton L, et al. (2012) Decidua Parietalis-derived mesenchymal cells reside in a vascular niche within the choridecidua. Reprod Sci 19: 1302-1314.
30. Garfias Y, Nieves-Hernandez J, Garcia-Mejia M, Estrada-Reyes C, Jimenez-Martinex MC, (2012) Stem cells isolated from human stromal limbus possess immunosuppressant properties. Mol Vis 18: 2087-2095.
31. Lee KS, Nah JJ, Lee BC, Lee HT, Lee HS, et al. (2013) Maintenance and characterization of multipotent mesenchymal stem cells isolated from canine umbilical cord matrix by collagenase digestion. Res Vet Sci Res Vet Sci 94: 144-151.
32. Gore A, Li Z, Fung HL, Young JE, Agarwal S, et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67.
33. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, et al. (2011) Copy number variation and selection during reprogramming to pluripotency. Nature 471: 58-62.
34. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, et al. (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471: 68-73.
35. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, et al. (2010) Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7: 521-531.
36. Jung Y, Bauer G, Nolta JA, (2012) Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30: 42-47.
37. Fierro F, Kalomoiris S, Sondergaard C, Nolta JA, (2011) Effetcs on proliferation and differentiation of multipotent bone marrow stromal cella engineered to express growth factors for combined cell and gene therapy. Stem Cells 29: 1727-1737.
38. Vaculik C, Schuster C, Bauer W, Iram N, Pfisterer K, et al. (2012) Human Dermis Harbors Distinct Mesenchymal Stromal Cell Subsets. J Invest Dermatol 132: 563-574.
39. Headington JT, (1986) The dermal dendrocyte. Adv Dermatol 1: 159-171.
40. Cerio R, Griffiths CE, Cooper KD, Nickoloff BJ, Headington JT, (1989) Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989; 121: 421-431.
41. Nickoloff BJ, (1991) The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle shaped cells in Kaposi's sarcoma. Arch Dermatol 127: 523-529.
42. Abboud ER, Shelby BD, Angelova M, Nelson AB, Ferris MB, et al. (2013) Kaposi sarcoma-associated Herpessvirus G protein- coupled receptor enhances endothelial cell survival in part by upregulation of bcl-2. Ochsner J 13: 66-75.
43. Kaiserling E, (2004) Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology. Pathologe 25: 362-364.
44. Pyakurel P, Pak F, Mwakigonja AR, Kaaya E, Heiden T, et al. (2006) Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. Int J Cancer 119: 1262-1267.
45. Bauer G, Dao MA, Case SS, Meyerrose T, Wirthlin L, et al. (2008) In vivo biosafety model to assess the risk of adverse events from retroviral and lentoviral vectors. Mol Ther 16: 1308-1315.
46. Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, et al. (2013) An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 24: 257-263.